Simulating therapeutic drug monitoring results for dose individualisation to maintain investigator blinding in a randomised controlled trial
Crossref DOI link: https://doi.org/10.1186/s13063-017-1992-6
Published Online: 2017-06-07
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lesosky, Maia http://orcid.org/0000-0002-2026-958X
Joska, John
Decloedt, Eric
Funding for this research was provided by:
European and Developing Countries Clinical Trials Partnership (SP.2011.41304.065)